The global immunohistochemistry market size is expected to reach USD 3.50 billion by 2030. The market is expected to register a CAGR of 5.8% from 2023 to 2030. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.
The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.
Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.
The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.
Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.
Immunohistochemistry Market Report Highlights
- The antibodies product segment led the market in 2022 owing to the high use of antibodies for immunohistochemistry assays carried out for disease diagnosis and drug testing workflows
- The diagnostics application segment led the market in 2022 owing to the widespread application of IHC tests in diagnostic settings
- The drug testing segment is expected to witness significant growth during the forecast period. This is due to increasing investment flow by pharmaceutical companies in R&D activities of novel drug discovery and development
- The hospitals and diagnostic laboratories end-use segment accounted for the largest revenue share in 2022. Research institutes are expected to register the fastest CAGR over the forecast period owing to the increasing adoption of IHC in research institutes for drug discovery activities
- North America emerged as the largest regional market in 2022 owing to the confluence of multiple factors, such as high cancer prevalence, presence of key players, and developed healthcare & biotechnological sectors
- The Asia Pacific is projected to grow at the fastest CAGR over the forecast period with China being the fastest-growing market. Increasing regulatory approvals and the launch of novel IHC solutions in China are accelerating the country’s market growth
- Key players are engaged in making focused attempts to reinforce their market position and gain a competitive advantage
Table of Contents
Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 End-Use Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 End-Use Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product and Application Snapshot
2.3. End-use Snapshot
2.4. Competitive Landscape Snapshot
2.2. Product and Application Snapshot
2.3. End-use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Emergence of multiplexed immunohistochemistry
3.4.2. Implementation of automation and machine learning in IHC
3.4.3. Increase in prevalence of cancer
3.5. Market Restraint Analysis
3.5.1. High instrument cost
3.5.2. Limitations associated with IHC technique
3.6. Industry Challenges
3.6.1. Quality assurance and standardization-related challenges
3.6.2. Limited scope for multiple evaluations
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Emergence of multiplexed immunohistochemistry
3.4.2. Implementation of automation and machine learning in IHC
3.4.3. Increase in prevalence of cancer
3.5. Market Restraint Analysis
3.5.1. High instrument cost
3.5.2. Limitations associated with IHC technique
3.6. Industry Challenges
3.6.1. Quality assurance and standardization-related challenges
3.6.2. Limited scope for multiple evaluations
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Immunohistochemistry Market: Segment Analysis by Product, 2018 - 2030 (USD Million)
4.1. Immunohistochemistry Market: Product Movement Analysis
4.2. Immunohistochemistry Market: Product Estimates and Forecasts, By Application (USD Million)
4.3. Antibodies
4.3.1. Antibodies Market, 2018 - 2030 (USD Million)
4.3.2. Primary Antibodies
4.3.2.1. Primary Antibodies Market, 2018 - 2030 (USD Million)
4.3.3. Secondary Antibodies
4.3.3.1. Secondary Antibodies Market, 2018 - 2030 (USD Million)
4.4. Equipment
4.4.1. Equipment Market, 2018 - 2030 (USD Million)
4.4.2. Slide Staining Systems
4.4.2.1. Slide Staining Systems Market, 2018 - 2030 (USD Million)
4.4.3. Tissue Microarrays
4.4.3.1. Tissue Microarrays Market, 2018 - 2030 (USD Million)
4.4.4. Tissue Processing Systems
4.4.4.1. Tissue Processing Systems Market, 2018 - 2030 (USD Million)
4.4.5. Slide Scanners
4.4.5.1. Slide Scanners Market, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market, 2018 - 2030 (USD Million)
4.5. Reagents
4.5.1. Reagents Market, 2018 - 2030 (USD Million
4.5.2. Histological Stains
4.5.2.1. Histological Stains Market, 2018 - 2030 (USD Million)
4.5.3. Blocking Sera And Reagents
4.5.3.1. Blocking Sera and Reagents Market, 2018 - 2030 (USD Million)
4.5.4. Chromogenic Substrates
4.5.4.1. Chromogenic Substrates Market, 2018 - 2030 (USD Million)
4.5.5. Fixation Reagents
4.5.5.1. Fixation Reagents Market, 2018 - 2030 (USD Million)
4.5.6. Organic Solvents
4.5.6.1. Organic Solvents Market, 2018 - 2030 (USD Million)
4.5.7. Proteolytic Enzymes
4.5.7.1. Proteolytic Enzymes Market, 2018 - 2030 (USD Million)
4.5.8. Diluents
4.5.8.1. Diluents Market, 2018 - 2030 (USD Million)
4.5.9. Others
4.5.9.1. Others Market, 2018 - 2030 (USD Million)
4.6. Kits
4.6.1. Kits Market, 2018 - 2030 (USD Million)
4.2. Immunohistochemistry Market: Product Estimates and Forecasts, By Application (USD Million)
4.3. Antibodies
4.3.1. Antibodies Market, 2018 - 2030 (USD Million)
4.3.2. Primary Antibodies
4.3.2.1. Primary Antibodies Market, 2018 - 2030 (USD Million)
4.3.3. Secondary Antibodies
4.3.3.1. Secondary Antibodies Market, 2018 - 2030 (USD Million)
4.4. Equipment
4.4.1. Equipment Market, 2018 - 2030 (USD Million)
4.4.2. Slide Staining Systems
4.4.2.1. Slide Staining Systems Market, 2018 - 2030 (USD Million)
4.4.3. Tissue Microarrays
4.4.3.1. Tissue Microarrays Market, 2018 - 2030 (USD Million)
4.4.4. Tissue Processing Systems
4.4.4.1. Tissue Processing Systems Market, 2018 - 2030 (USD Million)
4.4.5. Slide Scanners
4.4.5.1. Slide Scanners Market, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market, 2018 - 2030 (USD Million)
4.5. Reagents
4.5.1. Reagents Market, 2018 - 2030 (USD Million
4.5.2. Histological Stains
4.5.2.1. Histological Stains Market, 2018 - 2030 (USD Million)
4.5.3. Blocking Sera And Reagents
4.5.3.1. Blocking Sera and Reagents Market, 2018 - 2030 (USD Million)
4.5.4. Chromogenic Substrates
4.5.4.1. Chromogenic Substrates Market, 2018 - 2030 (USD Million)
4.5.5. Fixation Reagents
4.5.5.1. Fixation Reagents Market, 2018 - 2030 (USD Million)
4.5.6. Organic Solvents
4.5.6.1. Organic Solvents Market, 2018 - 2030 (USD Million)
4.5.7. Proteolytic Enzymes
4.5.7.1. Proteolytic Enzymes Market, 2018 - 2030 (USD Million)
4.5.8. Diluents
4.5.8.1. Diluents Market, 2018 - 2030 (USD Million)
4.5.9. Others
4.5.9.1. Others Market, 2018 - 2030 (USD Million)
4.6. Kits
4.6.1. Kits Market, 2018 - 2030 (USD Million)
Chapter 5. Immunohistochemistry Market: Segment Analysis by Application, 2018 - 2030 (USD Million
5.1. Immunohistochemistry Market: Application Movement Analysis
5.2. Immunohistochemistry Market: Application Estimates and Forecasts, By Application (USD Million)
5.3. Diagnostics
5.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
5.3.2. Cancer
5.3.3. Cancer Market, 2018 - 2030 (USD Million)
5.3.4. Infectious Diseases
5.3.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
5.3.5. Cardiovascular Diseases
5.3.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
5.3.6. Autoimmune Diseases
5.3.6.1. Autoimmune Diseases Market, 2018 - 2030 (USD Million)
5.3.7. Diabetes Mellitus
5.3.7.1. Diabetes Mellitus Market, 2018 - 2030 (USD Million)
5.3.8. Nephrological Diseases
5.3.8.1. Nephrological Diseases Market, 2018 - 2030 (USD Million)
5.4. Research
5.4.1. Research Market, 2018 - 2030 (USD Million)
5.2. Immunohistochemistry Market: Application Estimates and Forecasts, By Application (USD Million)
5.3. Diagnostics
5.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
5.3.2. Cancer
5.3.3. Cancer Market, 2018 - 2030 (USD Million)
5.3.4. Infectious Diseases
5.3.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
5.3.5. Cardiovascular Diseases
5.3.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
5.3.6. Autoimmune Diseases
5.3.6.1. Autoimmune Diseases Market, 2018 - 2030 (USD Million)
5.3.7. Diabetes Mellitus
5.3.7.1. Diabetes Mellitus Market, 2018 - 2030 (USD Million)
5.3.8. Nephrological Diseases
5.3.8.1. Nephrological Diseases Market, 2018 - 2030 (USD Million)
5.4. Research
5.4.1. Research Market, 2018 - 2030 (USD Million)
Chapter 6. Immunohistochemistry Market: Segment Analysis by End-use, 2018 - 2030 (USD Million)
6.1. Immunohistochemistry Market: End-use Movement Analysis
6.2. Immunohistochemistry Market: End-use Estimates and Forecasts, By Application (USD Million)
6.3. Hospitals & Diagnostic Laboratories
6.3.1. Hospitals & Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
6.4. Research Institutes
6.4.1. Research Institutes Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
6.2. Immunohistochemistry Market: End-use Estimates and Forecasts, By Application (USD Million)
6.3. Hospitals & Diagnostic Laboratories
6.3.1. Hospitals & Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
6.4. Research Institutes
6.4.1. Research Institutes Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Immunohistochemistry Market: Regional Analysis, 2018 - 2030 (USD Million)
7.1. Immunohistochemistry Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Immunohistochemistry Market, 2018 - 2030 (USD MILLION)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. Germany Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.4. UK
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. UK Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. South Korea Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Australia Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.8. Thailand
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. Thailand Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Immunohistochemistry Market, 2018 - 2030 (USD MILLION)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. Germany Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.4. UK
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. UK Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. South Korea Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Australia Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.4.8. Thailand
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. Thailand Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Immunohistochemistry Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Immunohistochemistry Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 NEW PRODUCT LAUNCH
8.2.2 PARTNERSHIPS
8.2.3 ACQUISITION
8.2.4 COLLABORATION
8.2.5 FUNDING
8.3 Key Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 Thermo Fisher Scientific Inc.
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 F.Hoffmann-La Roche Ltd.
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 Merck KGaA
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 Danaher Corporation
8.4.4.1 Company overview
8.4.4.2 Product benchmarking
8.4.4.3 Strategic Initiatives
8.4.5 Perkinelmer, Inc.
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic Initiatives
8.4.6 Bio-Rad Laboratories, Inc.
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 Cell Signaling Technology Inc.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic Initiatives
8.4.8 Bio SB
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 Agilent Technologies, Inc.
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic Initiatives
8.4.10 Abcam Plc.
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic Initiatives
8.2 Strategy Mapping
8.2.1 NEW PRODUCT LAUNCH
8.2.2 PARTNERSHIPS
8.2.3 ACQUISITION
8.2.4 COLLABORATION
8.2.5 FUNDING
8.3 Key Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 Thermo Fisher Scientific Inc.
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 F.Hoffmann-La Roche Ltd.
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 Merck KGaA
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 Danaher Corporation
8.4.4.1 Company overview
8.4.4.2 Product benchmarking
8.4.4.3 Strategic Initiatives
8.4.5 Perkinelmer, Inc.
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic Initiatives
8.4.6 Bio-Rad Laboratories, Inc.
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 Cell Signaling Technology Inc.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic Initiatives
8.4.8 Bio SB
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 Agilent Technologies, Inc.
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic Initiatives
8.4.10 Abcam Plc.
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Immunohistochemistry Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 5 Global Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 6 Global Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 7 North America Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 9 North America Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 10 North America Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 11 U.S. Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 12 U.S. Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 13 U.S. Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 14 Canada Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 15 Canada Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 16 Canada Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 17 Europe Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 19 Europe Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 20 Europe Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 21 Germany Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 22 Germany Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 23 Germany Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 24 UK Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 25 UK Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 26 UK Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 27 France Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 28 France Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 29 France Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 30 Italy Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 31 Italy Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 32 Italy Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 33 Spain Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 34 Spain Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 35 Spain Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 36 Denmark Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 37 Denmark Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 38 Denmark Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 39 Sweden Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 40 Sweden Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 41 Sweden Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 42 Norway Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 43 Norway Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 44 Norway Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 49 China Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 50 China Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 51 China Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 52 Japan Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 53 Japan Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 54 Japan Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 55 India Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 56 India Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 57 India Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 58 South Korea Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 59 South Korea Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 60 South Korea Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 61 Australia Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 62 Australia Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 63 Australia Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 64 Thailand Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 65 Thailand Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 66 Thailand Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 67 Latin America Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 68 Latin America Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 69 Latin America Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 70 Latin America Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 71 Brazil Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 72 Brazil Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 73 Brazil Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 74 Mexico Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 75 Mexico Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 76 Mexico Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 77 Argentina Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 78 Argentina Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 79 Argentina Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 84 South Africa Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 85 South Africa Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 86 South Africa Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 90 UAE Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 91 UAE Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 92 UAE Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 93 Kuwait Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 94 Kuwait Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 95 Kuwait Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Global Immunohistochemistry Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 5 Global Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 6 Global Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 7 North America Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 9 North America Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 10 North America Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 11 U.S. Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 12 U.S. Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 13 U.S. Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 14 Canada Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 15 Canada Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 16 Canada Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 17 Europe Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 19 Europe Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 20 Europe Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 21 Germany Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 22 Germany Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 23 Germany Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 24 UK Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 25 UK Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 26 UK Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 27 France Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 28 France Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 29 France Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 30 Italy Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 31 Italy Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 32 Italy Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 33 Spain Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 34 Spain Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 35 Spain Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 36 Denmark Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 37 Denmark Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 38 Denmark Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 39 Sweden Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 40 Sweden Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 41 Sweden Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 42 Norway Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 43 Norway Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 44 Norway Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 49 China Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 50 China Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 51 China Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 52 Japan Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 53 Japan Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 54 Japan Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 55 India Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 56 India Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 57 India Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 58 South Korea Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 59 South Korea Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 60 South Korea Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 61 Australia Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 62 Australia Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 63 Australia Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 64 Thailand Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 65 Thailand Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 66 Thailand Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 67 Latin America Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 68 Latin America Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 69 Latin America Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 70 Latin America Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 71 Brazil Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 72 Brazil Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 73 Brazil Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 74 Mexico Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 75 Mexico Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 76 Mexico Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 77 Argentina Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 78 Argentina Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 79 Argentina Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Immunohistochemistry Market, by Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 84 South Africa Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 85 South Africa Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 86 South Africa Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 90 UAE Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 91 UAE Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 92 UAE Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
Table 93 Kuwait Immunohistochemistry Market, by Product, 2018 - 2030 (USD Million)
Table 94 Kuwait Immunohistochemistry Market, by Application, 2018 - 2030 (USD Million)
Table 95 Kuwait Immunohistochemistry Market, by End-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Immunohistochemistry Market Segmentation
FIG. 8 Market Snapshot, 2022
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2022
FIG. 16 Global Immunohistochemistry Market: by Product Movement Analysis
FIG. 17 Global Immunohistochemistry Market, for Antibodies, 2018 - 2030 (USD Million)
FIG. 18 Global Immunohistochemistry Market, for Primary Antibodies, 2018 - 2030 (USD Million)
FIG. 19 Global Immunohistochemistry Market, for Secondary Antibodies, 2018 - 2030 (USD Million)
FIG. 20 Global Immunohistochemistry Market, for Reagents, 2018 - 2030 (USD Million)
FIG. 21 Global Immunohistochemistry Market, for Histological Stains, 2018 - 2030 (USD Million)
FIG. 22 Global Immunohistochemistry Market, for Blocking Sera and Reagents, 2018 - 2030 (USD Million)
FIG. 23 Global Immunohistochemistry Market, for Chromogenic Substrates, 2018 - 2030 (USD Million)
FIG. 24 Global Immunohistochemistry Market, for Fixation Reagents, 2018 - 2030 (USD Million)
FIG. 25 Global Immunohistochemistry Market, for Organic Solvents, 2018 - 2030 (USD Million)
FIG. 26 Global Immunohistochemistry Market, for Proteolytic Enzymes, 2018 - 2030 (USD Million)
FIG. 27 Global Immunohistochemistry Market, for Diluents, 2018 - 2030 (USD Million)
FIG. 28 Global Immunohistochemistry Market, for Other reagents, 2018 - 2030 (USD Million)
FIG. 29 Global Immunohistochemistry Market, for Equipment, 2018 - 2030 (USD Million)
FIG. 30 Global Immunohistochemistry Market, for Slide Staining Systems, 2018 - 2030 (USD Million)
FIG. 31 Global Immunohistochemistry Market, for Tissue Microarrays, 2018 - 2030 (USD Million)
FIG. 32 Global Immunohistochemistry Market, for Tissue Processing Systems, 2018 - 2030 (USD Million)
FIG. 33 Global Immunohistochemistry Market, for Slide Scanners, 2018 - 2030 (USD Million)
FIG. 34 Global Immunohistochemistry Market, for Others, 2018 - 2030 (USD Million)
FIG. 35 Global Immunohistochemistry Market, for Kits, 2018 - 2030 (USD Million)
FIG. 36 Global Immunohistochemistry Market: Application, Movement Analysis
FIG. 37 Global Immunohistochemistry Market, for Diagnostic Applications, 2018 - 2030 (USD Million)
FIG. 38 Global Immunohistochemistry Market, for Cancer 2018 - 2030 (USD Million)
FIG. 39 Global Immunohistochemistry Market, for Infectious Diseases 2018 - 2030 (USD Million)
FIG. 40 Global Immunohistochemistry Market, for Autoimmune Diseases 2018 - 2030 (USD Million)
FIG. 41 Global Immunohistochemistry Market, for Neurodegenerative Disorders 2018 - 2030 (USD Million)
FIG. 42 Global Immunohistochemistry Market, for Brain Trauma 2018 - 2030 (USD Million)
FIG. 43 Global Immunohistochemistry Market, for Others 2018 - 2030 (USD Million)
FIG. 44 Global Immunohistochemistry Market, for Research Applications 2018 - 2030 (USD Million)
FIG. 45 Global Immunohistochemistry Market: End use, Movement Analysis
FIG. 46 Global Immunohistochemistry Market, for Hospitals and Diagnostic Laboratories 2018 - 2030 (USD Million)
FIG. 47 Global Immunohistochemistry Market, for Research Institutes 2018 - 2030 (USD Million)
FIG. 48 Global Immunohistochemistry Market, for Others 2018 - 2030 (USD Million)
FIG. 49 Regional Marketplace: Key Takeaways Immunohistochemistry Market, Region 2018 - 2030 (USD Million)
FIG. 50 Regional Outlook, 2022 & 2030 Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 51 Global Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 52 North America Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 53 U.S. Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 54 Canada Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 55 Europe Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 56 Germany Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 57 UK Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 58 France Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 59 Italy Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 60 Spain Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 61 Denmark Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 62 Sweden Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 63 Norway Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 64 Asia Pacific Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 65 Japan Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 66 China Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 67 India Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 68 Australia Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 69 South Korea Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 70 Thailand Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 71 Latin America Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 72 Brazil Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 73 Mexico Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 74 Argentina Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 75 Middle East and Africa Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 76 South Africa Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 77 Saudi Arabia Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 78 UAE Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 79 Kuwait Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Immunohistochemistry Market Segmentation
FIG. 8 Market Snapshot, 2022
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2022
FIG. 16 Global Immunohistochemistry Market: by Product Movement Analysis
FIG. 17 Global Immunohistochemistry Market, for Antibodies, 2018 - 2030 (USD Million)
FIG. 18 Global Immunohistochemistry Market, for Primary Antibodies, 2018 - 2030 (USD Million)
FIG. 19 Global Immunohistochemistry Market, for Secondary Antibodies, 2018 - 2030 (USD Million)
FIG. 20 Global Immunohistochemistry Market, for Reagents, 2018 - 2030 (USD Million)
FIG. 21 Global Immunohistochemistry Market, for Histological Stains, 2018 - 2030 (USD Million)
FIG. 22 Global Immunohistochemistry Market, for Blocking Sera and Reagents, 2018 - 2030 (USD Million)
FIG. 23 Global Immunohistochemistry Market, for Chromogenic Substrates, 2018 - 2030 (USD Million)
FIG. 24 Global Immunohistochemistry Market, for Fixation Reagents, 2018 - 2030 (USD Million)
FIG. 25 Global Immunohistochemistry Market, for Organic Solvents, 2018 - 2030 (USD Million)
FIG. 26 Global Immunohistochemistry Market, for Proteolytic Enzymes, 2018 - 2030 (USD Million)
FIG. 27 Global Immunohistochemistry Market, for Diluents, 2018 - 2030 (USD Million)
FIG. 28 Global Immunohistochemistry Market, for Other reagents, 2018 - 2030 (USD Million)
FIG. 29 Global Immunohistochemistry Market, for Equipment, 2018 - 2030 (USD Million)
FIG. 30 Global Immunohistochemistry Market, for Slide Staining Systems, 2018 - 2030 (USD Million)
FIG. 31 Global Immunohistochemistry Market, for Tissue Microarrays, 2018 - 2030 (USD Million)
FIG. 32 Global Immunohistochemistry Market, for Tissue Processing Systems, 2018 - 2030 (USD Million)
FIG. 33 Global Immunohistochemistry Market, for Slide Scanners, 2018 - 2030 (USD Million)
FIG. 34 Global Immunohistochemistry Market, for Others, 2018 - 2030 (USD Million)
FIG. 35 Global Immunohistochemistry Market, for Kits, 2018 - 2030 (USD Million)
FIG. 36 Global Immunohistochemistry Market: Application, Movement Analysis
FIG. 37 Global Immunohistochemistry Market, for Diagnostic Applications, 2018 - 2030 (USD Million)
FIG. 38 Global Immunohistochemistry Market, for Cancer 2018 - 2030 (USD Million)
FIG. 39 Global Immunohistochemistry Market, for Infectious Diseases 2018 - 2030 (USD Million)
FIG. 40 Global Immunohistochemistry Market, for Autoimmune Diseases 2018 - 2030 (USD Million)
FIG. 41 Global Immunohistochemistry Market, for Neurodegenerative Disorders 2018 - 2030 (USD Million)
FIG. 42 Global Immunohistochemistry Market, for Brain Trauma 2018 - 2030 (USD Million)
FIG. 43 Global Immunohistochemistry Market, for Others 2018 - 2030 (USD Million)
FIG. 44 Global Immunohistochemistry Market, for Research Applications 2018 - 2030 (USD Million)
FIG. 45 Global Immunohistochemistry Market: End use, Movement Analysis
FIG. 46 Global Immunohistochemistry Market, for Hospitals and Diagnostic Laboratories 2018 - 2030 (USD Million)
FIG. 47 Global Immunohistochemistry Market, for Research Institutes 2018 - 2030 (USD Million)
FIG. 48 Global Immunohistochemistry Market, for Others 2018 - 2030 (USD Million)
FIG. 49 Regional Marketplace: Key Takeaways Immunohistochemistry Market, Region 2018 - 2030 (USD Million)
FIG. 50 Regional Outlook, 2022 & 2030 Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 51 Global Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 52 North America Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 53 U.S. Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 54 Canada Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 55 Europe Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 56 Germany Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 57 UK Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 58 France Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 59 Italy Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 60 Spain Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 61 Denmark Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 62 Sweden Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 63 Norway Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 64 Asia Pacific Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 65 Japan Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 66 China Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 67 India Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 68 Australia Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 69 South Korea Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 70 Thailand Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 71 Latin America Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 72 Brazil Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 73 Mexico Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 74 Argentina Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 75 Middle East and Africa Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 76 South Africa Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 77 Saudi Arabia Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 78 UAE Immunohistochemistry Market, 2018 - 2030 (USD Million)
FIG. 79 Kuwait Immunohistochemistry Market, 2018 - 2030 (USD Million)
Companies Mentioned
- Thermo Fisher Scientific Inc.
- F.Hoffmann-La Roche Ltd.
- Merck KGaA
- Danaher Corporation
- Perkinelmer, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology Inc.
- Bio SB
- Agilent Technologies, Inc.
- Abcam Plc.
Methodology
LOADING...
